Meredith Pelster, Meredith Pelster, MD, MSCI

Associate Director, GI Cancer Research Program Sarah Cannon Research Institute
Partner, SCRI Oncology Partners
Dr. Pelster received her undergraduate and medical degrees from Vanderbilt University, where she was the Founder’s Medalist for the College of Arts and Sciences and a member of the Alpha Omega Alpha medical honor society. She completed her internal medicine residency at Northwestern Memorial Hospital in Chicago, where she also served as a chief medical resident and earned her Master of Science in Clinical Investigation. Her oncology fellowship training was completed at MD Anderson Cancer Center. She joined Sarah Cannon Research Institute in 2021 as an investigator in GI and head and neck malignancies and subsequently assumed the role of Associate Director of the GI Cancer Research Program in 2022. Clinically, she cares for patients with a variety of GI cancers across the treatment spectrum – from patients on surveillance after prior GI cancer treatment to patients seeking novel therapies in phase 1 trials.
Financial relationships
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:AbbvieTopic:Paid to Institution for work as PIDate added:05/13/2025Date updated:05/13/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Accent TherapeuticsTopic:Paid to Institution for work as PIDate added:05/13/2025Date updated:05/13/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Acepodia BiotechTopic:Paid to Institution for work as PIDate added:05/13/2025Date updated:05/13/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Affini-T TherapeuticsTopic:Paid to Institution for work as PIDate added:05/13/2025Date updated:05/13/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:AgenusTopic:Paid to Institution for work as PIDate added:05/13/2025Date updated:05/13/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Arcus BiosciencesTopic:Paid to Institution for work as PIDate added:05/13/2025Date updated:05/13/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:AstraZenecaTopic:Paid to Institution for work as PIDate added:05/13/2025Date updated:05/13/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:BeiGeneTopic:Paid to Institution for work as PIDate added:05/13/2025Date updated:05/13/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:BioNTechTopic:Paid to Institution for work as PIDate added:05/13/2025Date updated:05/13/2025
-
Attribution:SelfType of financial relationship:Grant Or ContractIneligible company:Boehringer IngelheimTopic:Paid to Institution for work as PIDate added:05/13/2025Date updated:05/13/2025